Obesity-related increased γ' fibrinogen concentration in children and its reduction by a physical activity-based lifestyle intervention: A randomized controlled study

Journal of Pediatrics

Volumn 163, Issue 2, 2013, Pages 333-338

  Lovely, Rehana ^a   Hossain, Jobayer ^b   Ramsey, Jonathen P ^c   Komakula, Venugopal ^c   George, Donald ^d   Farrell, David H ^e   Balagopal, Prabhakaran ^d  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c MISSOURI STATE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

BMI; Body mass index; Bovine serum albumin; BSA; C reactive protein; Cardiovascular disease; CRP; CVD; DEXA; Dual energy X ray absorptiometry; HOMA IR; Homeostasis model of assessment insulin resistance; IL; Interleukin; PBS; Phosphate buffered saline

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GAMMA FIBRINOGEN; INSULIN; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FIBRINOLYSIS; HUMAN; HYPERFIBRINOGENEMIA; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MALE; OBESITY; PHYSICAL ACTIVITY; POPULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; THROMBOSIS;

BMI; BODY MASS INDEX; BOVINE SERUM ALBUMIN; BSA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASE; CRP; CVD; DEXA; DUAL-ENERGY X-RAY ABSORPTIOMETRY; HOMA-IR; HOMEOSTASIS MODEL OF ASSESSMENT-INSULIN RESISTANCE; IL; INTERLEUKIN; PBS; PHOSPHATE-BUFFERED SALINE;

ADIPOSITY; ADOLESCENT; CARDIOVASCULAR DISEASES; EXERCISE; FEMALE; FIBRINOGEN; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE; MOTOR ACTIVITY; OBESITY; RISK FACTORS;

EID: 84880618613     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.01.004     Document Type: Article

References (37)

1. Fibrinogen Studies Collaboration Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies Am J Epidemiol 166 2007 867 879
2. J.J. Stec, H. Silbershatz, G.H. Tofler, T.H. Matheney, P. Sutherland, and I. Lipinska Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population Circulation 102 2000 1634 1638
3. D. Green, N. Foiles, C. Chan, P.J. Schreiner, and K. Liu Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study Atherosclerosis 202 2009 623 631
4. P.A. Sakkinen, P. Wahl, M. Cushman, M.R. Lewis, and R.P. Tracy Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome Am J Epidemiol 152 2000 897 907
5. D. Green, C. Chan, J. Kang, K. Liu, P. Schreiner, and N.S. Jenny Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study J Thromb Haemost 8 2010 489 495
6. K.R. Machlus, J.C. Cardenas, F.C. Church, and A.S. Wolberg Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice Blood 117 2011 4953 4963
7. E. Ernst The role of fibrinogen as a cardiovascular risk factor Atherosclerosis 100 1993 1 12
8. P. Balagopal, D. George, S. Sweeten, K.J. Mann, H. Yarandi, and N. Mauras Response of fractional synthesis rate (FSR) of fibrinogen, D-dimer and fibrinolytic balance to physical activity-based intervention in obese children J Thromb Haemost 6 2008 1296 1303
9. B. Gutin, M.H. Johnson, M.C. Humphries, J.L. Hatfield-Laube, G.K. Kapuku, and J.D. Allison Relationship of visceral adiposity to cardiovascular disease risk factors in black and white teens Obesity 15 2007 1029 1035
10. M.A. Ferguson, B. Gutin, S. Owens, M. Litaker, R.P. Tracy, and J. Allison Fat distribution and hemostatic measures in obese children Am J Clin Nutr 67 1998 1136 1140
11. J.B. Albu, J. Lu, A.D. Mooradian, R.J. Krone, R.W. Nesto, and M.H. Porter Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Obesity 18 2010 1046 1054
12. P. Balagopal, S.D. de Ferranti, S. Cook, S.R. Daniels, S.S. Gidding, and L.L. Hayman Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association Circulation 123 2011 2749 2769
13. S.T. Lord Fibrinogen and fibrin: scaffold proteins in hemostasis Curr Opin Hematol 14 2007 236 241
14. J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel Influence of γ′-fibrinogen splice variant on fibrin physical properties and fibrinolysis rate Arterioscler Thromb Vasc Biol 24 2004 382 386
15. D.H. Farrell Pathophysiologic roles of the fibrinogen γ chain Curr Opin Hematol 11 2004 151 155
16. R.S. Lovely, S.C. Kazmierczak, J.M. Massaro, R.B. D'Agostino, C.J. O'Donnell, and D.H. Farrell γ′ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease Clin Chem 56 2010 781 788
17. S. Uitte de Willige, M.C.H. de Visser, J.J. Houwing-Duistermaat, F.R. Rosendaal, H.L. Vos, and R.M. Bertina Genetic variation in the fibrinogen γ gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels Blood 106 2005 4176 4183
18. K.S. Alexander, T.E. Madden, and D.H. Farrell Association between γ′ fibrinogen levels and inflammation Thromb Haemost 105 2011 605 609
19. S. Uitte de Willige, K.F. Standeven, H. Philippou, and R.A.S. Ariens The pleiotropic role of the fibrinogen γ′ chain in hemostasis Blood 114 2009 3994 4001
20. L. Drouet, F. Paolucci, N. Pasqualini, M. Laprade, L. Ripoll, and E. Mazoyer Plasma γ′/γ fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor? Blood Coagul Fibrinolysis 10 Suppl 1 1999 S35 S39
21. L.A. Falls, and D.H. Farrell Resistance of γA/γ′ fibrin clots to fibrinolysis J Biol Chem 272 1997 14251 14256
22. R.S. Lovely, L.A. Falls, H.A. Al-Mondhiry, C.E. Chambers, G.J. Sexton, and H. Ni Association of γA/γ′ fibrinogen levels and coronary artery disease Thromb Haemost 88 2002 26 31
23. E.Y.L. Cheung, S.U. de Willige, H.L. Vos, F.W.G. Leebeek, D.W.J. Dippel, and R.M. Bertina Fibrinogen γ′ in ischemic stroke Stroke 39 2008 1033 1035
24. R.S. Lovely, Q. Yang, J.M. Massaro, J. Wang, R.B. D'Agostino, and C.J. O'Donnell Assessment of genetic determinants of the association of γ′-fibrinogen in relation to cardiovascular disease Arterioscler Thromb Vasc Biol 31 2011 2345 2352
25. J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, and A. Ankri Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler Thromb Vasc Biol 26 2006 2567 2573
26. A. Silveira, and A. Hamsten Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease Arterioscler Thromb Vasc Biol 26 2006 2419 2420
27. A.Z. Fu, and K.S. Nair Age effect on fibrinogen and albumin synthesis in humans Am J Physiol 275 1998 E1023 E1030
28. P. Balagopal, D. George, N. Patton, H. Yarandi, W.L. Roberts, and E. Bayne Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents J Pediatr 146 2005 342 348
29. M.N. Mannila, R.S. Lovely, S.C. Kazmierczak, P. Eriksson, A. Samnegard, and D.H. Farrell Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors J Thromb Haemost 5 2007 766 773
30. I. Juhan-Vague, M.C. Alessi, and P. Vague Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis Diabetologia 34 1991 457 462
31. B.E. Sobel Increased plasminogen activator inhibitor-1 and vasculopathy: a reconcilable paradox Circulation 99 1999 2496 2498
32. M. Cushman, R.N. Lemaitre, L.H. Kuller, B.M. Psaty, E.M. Macy, and A.R. Sharrett Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study Arterioscler Thromb Vasc Biol 19 1999 493 498
33. D.E. Vaughan Plasminogen activator inhibitor-1 and vascular disease in diabetes mellitus M.T. Johnstone, A. Veves, Diabetes and cardiovascular disease 2001 Humana Press Totowa (NJ) 237 243
34. R. von Kañel, B.M. Kudielka, D. Hanebuth, D. Preckel, and J.E. Fischer Different contributions of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation Clin Sci 109 2005 61 67
35. C.M. Rein, N. Anderson, and D.H. Farrell Differential regulation of fibrinogen γ-chain splice isoforms by interleukin-6 Thrombos Res 131 2013 89 93 in press
36. P. De Feo, M.G. Gaisano, and M.W. Haymond Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans J Clin Invest 88 1991 833 840
37. R. Barazzoni, E. Kiwanuka, M. Zanetti, M. Cristini, M. Vettore, and P. Tessari Insulin acutely increases fibrinogen production in individuals with type 2 diabetes, but not in individuals without diabetes Diabetes 52 2003 1851 1856.